Mammostrat as a tool to stratify breast cancer patients at risk of recurrence during endocrine therapy. [electronic resource]
Producer: 20110301Description: R47 p. digitalISSN:- 1465-542X
- Antineoplastic Agents, Hormonal -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Breast Neoplasms -- diagnosis
- Carcinoembryonic Antigen -- metabolism
- Cell Cycle Proteins -- metabolism
- Chemotherapy, Adjuvant
- Diagnostic Tests, Routine -- methods
- Disease-Free Survival
- Female
- GPI-Linked Proteins -- metabolism
- Humans
- Immunohistochemistry
- Intracellular Signaling Peptides and Proteins -- metabolism
- Large Neutral Amino Acid-Transporter 1 -- metabolism
- Middle Aged
- Multivariate Analysis
- Neoplasm Recurrence, Local
- Prognosis
- Receptors, Estrogen -- metabolism
- Reproducibility of Results
- Risk Assessment -- methods
- Risk Factors
- Sensitivity and Specificity
- Tamoxifen -- therapeutic use
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.